• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.

作者信息

Kanie Yasukazu, Okamura Akihiko, Asari Takao, Ishiyama Akiyoshi, Yoshio Toshiyuki, Tsuchida Tomohiro, Chin Keisho, Watanabe Masayuki

机构信息

Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

Department of Radiation Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

出版信息

Ann Surg Oncol. 2021 Dec;28(13):8436-8437. doi: 10.1245/s10434-021-10261-1. Epub 2021 Jun 11.

DOI:10.1245/s10434-021-10261-1
PMID:34115253
Abstract
摘要

相似文献

1
ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.美国外科医师学会作者反思：食管癌切除术还是放化疗，这是个问题：食管鳞状细胞癌非根治性内镜切除术后的额外治疗
Ann Surg Oncol. 2021 Dec;28(13):8436-8437. doi: 10.1245/s10434-021-10261-1. Epub 2021 Jun 11.
2
ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.ASO作者反思：T1N0期食管鳞状细胞癌患者非根治性内镜切除术后追加食管切除术与直接食管切除术的比较
Ann Surg Oncol. 2021 Sep;28(9):4867-4868. doi: 10.1245/s10434-020-09502-6. Epub 2021 Jan 25.
3
ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?ASO作者反思：早期食管鳞状细胞癌非根治性内镜切除术后是否需要进行食管切除术？
Ann Surg Oncol. 2021 Nov;28(12):7160-7161. doi: 10.1245/s10434-021-10473-5. Epub 2021 Jul 15.
4
Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: A Comparison of Outcomes between Esophagectomy and Chemoradiotherapy.内镜下切除治疗食管鳞癌后附加治疗：食管切除术与放化疗的结局比较。
Ann Surg Oncol. 2021 Dec;28(13):8428-8435. doi: 10.1245/s10434-021-10225-5. Epub 2021 Jun 3.
5
Letter to the Editor: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.致编辑的信：非根治性内镜切除术后追加食管切除术与T1N0期食管鳞状细胞癌直接行食管切除术的疗效比较
Ann Surg Oncol. 2021 Dec;28(Suppl 3):837-838. doi: 10.1245/s10434-021-10102-1. Epub 2021 May 6.
6
Author's Reply: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.作者回复：非根治性内镜切除术后追加食管切除术与T1N0期食管鳞状细胞癌直接行食管切除术的疗效比较
Ann Surg Oncol. 2021 Dec;28(Suppl 3):839-840. doi: 10.1245/s10434-021-10104-z. Epub 2021 May 10.
7
ASO Author Reflections: Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma.ASO作者反思：最初不可切除的局部晚期T4食管鳞状细胞癌挽救性食管切除术的合适候选人
Ann Surg Oncol. 2020 Sep;27(9):3171-3172. doi: 10.1245/s10434-020-08441-6. Epub 2020 Apr 8.
8
ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.ASO作者反思：丝氨酸蛋白酶27是术前治疗的食管鳞状细胞癌的新型预后指标。
Ann Surg Oncol. 2021 Sep;28(9):5382-5383. doi: 10.1245/s10434-020-09580-6. Epub 2021 Jan 16.
9
ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma.ASO作者反思：局部晚期不可切除食管鳞状细胞癌的转化治疗
Ann Surg Oncol. 2023 Feb;30(2):871-872. doi: 10.1245/s10434-022-12776-7. Epub 2022 Nov 15.
10
ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.ASO作者反思：对新辅助化疗的反应增强了病理分期对食管鳞状细胞癌的预后影响。
Ann Surg Oncol. 2021 Dec;28(13):8448-8449. doi: 10.1245/s10434-021-10231-7. Epub 2021 Jun 18.